<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutations in the <z:chebi fb="36" ids="29309">methyl</z:chebi>-CpG-binding protein 2 (MECP2) gene are known to underlie <z:e sem="disease" ids="C0035372" disease_type="Disease or Syndrome" abbrv="RTT">Rett</z:e>' syndrome, the most common cause of <z:hpo ids='HP_0001249'>mental retardation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>) in girls </plain></SENT>
<SENT sid="1" pm="."><plain>Since the original report, phenotypes resulting from MECP2 mutations have been shown to extend, for example, to several <z:e sem="disease" ids="C0035372" disease_type="Disease or Syndrome" abbrv="RTT">Rett</z:e> variants, <z:hpo ids='HP_0000717'>autism</z:hpo>, atypical <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e>, and nonspecific <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>It was earlier proposed that MECP2 mutations might account for approximately 2% of the male cases with nonspecific <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Thereby, the frequency of MECP2 mutations in the mentally retarded population would be comparable to that of <z:e sem="disease" ids="C0016667" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Fragile-X syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this study was to analyze well-characterized cases with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> and to clarify the role of the MECP2 gene in the etiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> and atypical <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The coding sequence of the MECP2 gene was analyzed in a sample of 118 patients (103 males, 15 females) by direct sequencing </plain></SENT>
<SENT sid="6" pm="."><plain>Two coding sequence variants, 602C &gt; T (A201V) and 1189G &gt; A (E397K), were identified </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, we identified four variants in the intronic or 3'UTR regions </plain></SENT>
<SENT sid="8" pm="."><plain>None of these variants is likely to be causal </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that the evidence across <z:hpo ids='HP_0000001'>all</z:hpo> the mutation screening studies implies that MECP2 mutations do not represent a major cause of nonspecific <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> </plain></SENT>
</text></document>